Market Value7,095,729,000
Total Holdings95
File Date2014-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
MGNX / MacroGenics, Inc.
KYTH / Kythera Biopharma
BCRX / BioCryst Pharmaceuticals, Inc.
UTHR / United Therapeutics Corporation
CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock
CLVS / Clovis Oncology Inc
ZGNX / Zogenix Inc
SGMO / Sangamo Therapeutics, Inc.
AVNR / Avanir Pharmaceuticals Inc
PGNX / Progenics Pharmaceuticals, Inc.
PCYC / Pharmacyclics
AERI / Aerie Pharmaceuticals Inc
Arrowhead Research Corp. / (042797209)
US33830X1046 / Five Prime Therapeutics Inc
DYAX / Dyax Corp.
FMI / Foundation Medicine, Inc.
GALT / Galectin Therapeutics Inc.
ITMN /
Ligand Pharmaceuticals Inc. / CLASS B (53220K207)
ABUS / Arbutus Biopharma Corporation
Ventrus Biosciences, Inc. / (922822101)
Incyte Genomics Notes 4.75% 10/1/2015 144A / CONV BONDS (45337CAH5)
45337CAK8 / Incyte Corporation Bonds 0.375% 11/15/2018
Intermune Inc Notes 5% 3/1/15 / CONV BONDS (45884XAD5)
Intermune Inc Notes 2.5% 12/15/17 / CONV BONDS (45884XAF0)
Salix 2.75% 5/15/15 / CONV BONDS (795435AC0)
795435AE6 / Salix Pharmaceuticals Inc. Bond 1.5% 3/15/19
09061GAE1 / BioMarin Pharmaceutical Inc. Bond 0.75% 10/15/2018
GEVA / Synageva Biopharma Corp
VNDA / Vanda Pharmaceuticals Inc.
TGTX / TG Therapeutics, Inc.
GHDX / Genomic Health, Inc.
MEI Pharma, Inc. / (55279B103)
IDRA / Idera Pharmaceuticals, Inc.
INSM / Insmed Incorporated
HALO / Halozyme Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
INCY / Incyte Corporation
CERS / Cerus Corporation
DSCI / Derma Sciences, Inc.
RCPT / Receptos, Inc.
032420101 / Anacor Pharmaceuticals, Inc.
ZIOP / Alaunos Therapeutics Inc
GILD / Gilead Sciences, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
375558AP8 / Gilead Sciences, Inc. Bond 1.625% 5/1/16
58501NAA9 / Medivation, Inc. 2.625% Bond 4/1/17
XNPT / XenoPort, Inc.
WINT / Windtree Therapeutics, Inc.
OMER / Omeros Corporation
TSRO / TESARO, Inc.
OSUR / OraSure Technologies, Inc.
AEGR / Aegerion Pharmaceuticals, Inc.
02318X100 / Ambit Biosciences Corp
OSIR / Osiris Therapeutics, Inc.
IRWD / Ironwood Pharmaceuticals, Inc.
INFI / Infinity Pharmaceuticals Inc.
SLXP / Salix Therapeuticals, Inc.
MDVN / Medivation, Inc.
NVLN / NOVELION THERAPEUTICS INC.
FOLD / Amicus Therapeutics, Inc.
STML / Stemline Therapeutics, Inc.
ICPT / Intercept Pharmaceuticals Inc
QCOR /
09061GAD3 / BioMarin Pharmaceutical Inc. Bond 1.875% 4/23/2017
/ Array BioPharma, Inc.
05334DAA5 / Auxilium Pharmaceuticals Inc 1.5% Bond due 2018-07-15
Viropharma Inc. / (928241108)
TRGT / Targacept
CBST /
ARIA / ARIAD Pharmaceuticals, Inc.
76028H209 / Repros Therapeutics, Inc.
CHTP / Chelsea Therapeutics International, Ltd.
PRTA / Prothena Corporation plc
EPZM / Epizyme Inc
VXRT / Vaxart, Inc.
45337CAL6 / Incyte Corporation Bonds 1.25% 11/15/2020
XOMA / XOMA Royalty Corporation
BDSI / Biodelivery Sciences International
KPTI / Karyopharm Therapeutics Inc.
AGIO / Agios Pharmaceuticals, Inc.
SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
0PP / Portola Pharmaceuticals Inc
ISEE / IVERIC bio Inc
IONS / Ionis Pharmaceuticals, Inc.
PBYI / Puma Biotechnology, Inc.
BMRN / BioMarin Pharmaceutical Inc.
RIGL / Rigel Pharmaceuticals, Inc.
XLRN / Acceleron Pharma Inc
MTEM / Molecular Templates, Inc.
GWP / GW Pharmaceuticals plc
NVAX / Novavax, Inc.
CCXI / ChemoCentryx Inc
ENTA / Enanta Pharmaceuticals, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
GERN / Geron Corporation
SGEN / Seagen Inc
XNCR / Xencor, Inc.
MRTX / Mirati Therapeutics, Inc.
BLUE / bluebird bio, Inc.